Next Generation Systems CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biomarkers and Personalized Medicine CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biopharmaceutical Assessment CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Global Discovery Research Neuroscience and General Medicine PCU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Next Generation Systems CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biopharmaceutical Assessment CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biopharmaceutical Assessment CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biopharmaceutical Assessment CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Next Generation Systems CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Biopharmaceutical Assessment CFU, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Japan
Copyright © 2014 Kazuto Yamazaki, Taro Hihara, Hiroshi Kato, Tatsuto Fukushima, Kazuyuki Fukushima, Tomohiko Taniguchi, Takashi Yoshinaga, Norimasa Miyamoto, Masashi Ito, Kohei Sawada et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
K. Yamazaki, T. Hihara, H. Kato, T. Fukushima, K. Fukushima, T. Taniguchi, T. Yoshinaga, N. Miyamoto, M. Ito and K. Sawada, "Beat-to-Beat Variability in Field Potential Duration in Human Embryonic Stem Cell-Derived Cardiomyocyte Clusters for Assessment of Arrhythmogenic Risk, and a Case Study of Its Application,"
Pharmacology & Pharmacy, Vol. 5 No. 1, 2014, pp. 117-128. doi:
10.4236/pp.2014.51017.